Patent · US Active

Secnidazole for use in the treatment of bacterial vaginosis

US11684607B2 · kind B2 · utility

0Cited by
47References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2021
Grant dateJun 27, 2023
Priority date—
Expiry dateJun 12, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D233/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.